Lupron Depot

Product manufactured by Abbvie Inc.

Application Nr Approved Date Route Status External Links
NDA020517 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lupron Depot 7.5 Mg For 1-Month Administration, 22.5 Mg For 3-Month Administration, 30 Mg For 4-Month Administration, And 45 Mg For 6-Month Administration (Leuprolide Acetate) Are Indicated In The Palliative Treatment Of Advanced Prostatic Cancer. Lupron Depot Is A Gonadotropin Releasing Hormone (Gnrh) Agonist Indicated For: Palliative Treatment Of Advanced Prostatic Cancer. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Leuprolide Acetate

Comments